Explore PMOS Research
Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies2,601–2,620 of 20,710
All studies
Hypomethylation‐Triggered SERPINE1 (Serpin Family E Member 1) Exacerbates Polycystic Ovary Syndrome with Hyperandrogenism Induced by Circadian Disruption
Pyruvate kinase M2-mediated histone lactylation alters three-dimensional genomic architecture in polycystic ovary syndrome
The Impact of Melatonin Supplementation on Various Aspects of Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis
Correlation of AMH Levels with Clinical, Biochemical and Hormonal Parameters Among Infertile Women with PCOS.
Natural History of Cardiovascular Disease in Young Women: Cardiometabolic Risk, Atherosclerotic Cardiovascular Disease and Cardiac Function Is Exacerbated in Those With Polycystic Ovary Syndrome
Review for "Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges"
Conditioned media and extracellular vesicles derived from human Wharton's jelly mesenchymal stem cells improve the in vitro maturation of immature oocytes in normal and PCOS mouse model.
Galangin Mitigates Letrozole-Induced Polycystic Ovary Syndrome in Rats by Restoring PI3K/pAKT/PTEN Signaling
Mitochondria-targeted Antioxidant Therapy MitoTempo Attenuates Renal Injury in a Mouse Model of Polycystic Ovary Syndrome
Tubal patency testing in women with polycystic ovary syndrome − is it worth before ovarian induction: Cost-effectiveness analysis
Obesity but Not Polycystic Ovary Syndrome Associated with Decreased Breastfeeding Initiation Rates
Circulating adipokine concentrations aid in distinguishing functional hypothalamic amenorrhoea and polycystic ovary syndrome in women presenting with oligo/amenorrhoea
Estimation of Galanin hormone levels and additional biochemical markers in polycystic ovary syndrome patients
Polysaccharide–silane polymer composites: A novel electrically tunable drug delivery platform for Polycystic ovary syndrome treatment
Front Cover: α‐Linolenic Acid‐Rich Flaxseed Oil Improves Polycystic Ovary Syndrome via Regulating Lipid Metabolism by GPR120‐cAMP Pathway and Restoring Gut Microecology
POLYCYSTIC OVARY SYNDROME IN FOCUS: UNDERSTANDING HOW PATIENT EXPERIENCES AFFECT TREATMENT CHOICES
The effects of weight loss on hypothalamic dysfunction in a woman with polycystic ovary syndrome (PCOS)
Role of bile acids in the pathogenesis and metabolic abnormalities of polycystic ovary syndrome (PCOS)
Polycystic Ovary Syndrome (PCOS) as a Ovarian Insulin Sensitization Failure: A Triad Therapeutic Protocol